Published in Medical Letter on the CDC and FDA, July 14th, 1997
Testosterone induces susceptibility to P. chabaudi malaria by imposing restrictions on the mechanisms that mediate resistance, said W.P.M. Benten and colleagues, Heinrich Heine University, Dusseldorf, Germany.
Benten et al. performed a study to determine whether these restrictions cease after testosterone is withdrawn ("Testosterone-Induced Susceptibility to Plasmodium chabaudi Malaria: Persistence after Withdrawal of Testosterone," Journal of Endocrinology, 1997;153:275-281).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA